In Vitro Fertilization (IVF) Market - Trends Forecast Till 2028

Market Overview

The global In Vitro Fertilization /IVF market size is projected to reach USD 990 million by 2026 at a CAGR of 9.2% from USD 640 million in 2021 during the forecast period 2021-2028.

IVF or In vitro fertilization is a method of ART or assisted reproductive technology the deals with a complex set of procedure which help people with fertility and assist them in the conception of a child. In the procedure one or more fertilized eggs or embryos are transferred into the woman's uterus, where they may implant in the uterine lining and develop into foetus.

With the declining fertility rate and increased medial age of first-time mothers along with raised incidents of male infertility are some of the factors that have supported long-term expansion for In Vitro Fertilization /IVF Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. A similar effect has been observed in the sector as well. About 90% drop was recorded in the number of females going for IVF.

Regional Analysis

Asia Pacific is expected to be the largest market during the forecast period. Increased number of medical tourism along with increased awareness of IVF procedures and reduced treatment require along with the increased healthcare expenditure have led to growth of the market in the region.

Insights are provided for each region and major countries within the regions

Competitive Landscape

Key Players

• The Cooper Companies Inc.
• Cook Group
• Vitrolife
• Thermo Fisher Scientific, Inc.
• Esco Micro Pte. Ltd.
• Genea Limited
• IVFtech ApS
• FUJIFILM Irvine Scientific
• The Baker Company, Inc.
• Kitazato Corporation
• Rocket Medical plc
• Hamilton Thorne Ltd.
• ZEISS Group
• FERTIPRO NV
• Gynotec B.V

Recent Developments

• In 2021, FDA approved the commercialization of the GYNEMED GM501, manufacture by Hamilton Thorne Ltd which is a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.
• In 2021, CooperSurgical join hands with Virtus Health in order to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for In Vitro Fertilization /IVF market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope